Identifying and definitional attributes | |
Metadata item type: | Indicator |
---|---|
Indicator type: | Progress measure |
Short name: | PI 10–Prevalence of Type 2 diabetes, 2022 |
METEOR identifier: | 740876 |
Registration status: | Health, Standard 24/09/2021 |
Description: | The proportion of people who have Type 2 diabetes. |
Indicator set: | National Healthcare Agreement (2022) Health, Standard 24/09/2021 |
Outcome area: | Prevention Health, Standard 07/07/2010 |
Collection and usage attributes | |
Computation description: | The National Health Measures Survey component of the 2011–13 Australian Health Survey included a fasting plasma glucose test. A respondent to the survey is considered to have known diabetes if they had ever been told by a doctor or nurse that they have Type 2 diabetes and:
A respondent to the survey is considered to have newly diagnosed diabetes if they reported no prior diagnosis of diabetes, but had a fasting plasma glucose value greater than or equal to 7.0 mmol/L. Excludes persons who did not fast for 8 hours or more prior to their blood test. Excludes women with gestational diabetes. The data are reported for two age ranges:
Rates are directly age-standardised to the 2001 Australian population. Analysis by remoteness and Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage (IRSD) is based on usual residence of the person (based on data availability). Presented as a percentage. 95% confidence intervals and relative standard errors are calculated for rates. Note: The type of diabetes for newly diagnosed cases cannot be determined from a fasting plasma glucose or HbA1c test alone. However, it is assumed that the vast majority of newly diagnosed cases would be Type 2. |
---|---|
Computation: | Crude rate: 100 x (Numerator ÷ Denominator) |
Numerator: | Number of persons aged 18 and over with known diabetes (Type 2) or newly diagnosed diabetes as determined by a fasting plasma glucose test. For the supplementary measure: number of persons aged 25 and over with known diabetes (Type 2) or newly diagnosed diabetes as determined by a fasting plasma glucose test. |
Numerator data elements: | |
Denominator: | Population aged 18 and over. For the supplementary measure: population aged 25 and over. |
Denominator data elements: | |
Disaggregation: | State and territory, by:
Nationally, by (all not reported this cycle):
Some disaggregation may result in numbers too small for publication. |
Disaggregation data elements: | |
Comments: | Most recent data available for 2022 National Healthcare Agreement performance reporting: 2011–12 (total population, non-Indigenous: AHS); 2012–13 (Indigenous only: AATSIHS). NO NEW DATA FOR 2022 REPORTING. Data for the Northern Territory should be interpreted with caution as the AHS excluded discrete Aboriginal and Torres Strait Islander communities and very remote areas, which comprise around 30% of the estimated resident population of the Northern Territory. Further details on the prevalence of Type 2 diabetes among Indigenous Australians are available from the Aboriginal and Torres Strait Islander Health Performance Framework (measure 1.09: Diabetes and measure 3.05: Chronic disease management). |
Representational attributes | |
Representation class: | Percentage |
Data type: | Real |
Unit of measure: | Person |
Format: | N[NN].N |
Data source attributes | |
Data sources: | |
Accountability attributes | |
Reporting requirements: | National Healthcare Agreement |
Organisation responsible for providing data: | Australian Bureau of Statistics |
Benchmark: | |
Further data development / collection required: | Specification: Final, the measure meets the intention of the indicator. |
Source and reference attributes | |
Submitting organisation: | Australian Bureau of Statistics |
Reference documents: | Australian Bureau of Statistics (ABS) (Reference period: 2011–12). Australian Health Survey: Biomedical Results for Chronic Diseases, 2011–12. ABS Website. Viewed 22 February 2021, https://www.abs.gov.au/statistics/health/health-conditions-and-risks/australian-health-survey-biomedical-results-chronic-diseases/latest-release Australian Institute of Health and Welfare (AIHW) 2020. Aboriginal and Torres Strait Islander Health Performance Framework. Canberra: AIHW. Viewed 19 February 2021, https://indigenoushpf.gov.au/ |
Relational attributes | |
Related metadata references: | Supersedes National Healthcare Agreement: PI 10–Prevalence of Type 2 diabetes, 2021 Health, Standard 03/07/2020 See also Australian Health Performance Framework: PI 3.1.7–Prevalence of type 2 diabetes, 2020 Health, Standard 13/10/2021 See also National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2022 Health, Standard 24/09/2021 See also National Healthcare Agreement: PI 15–Effective management of diabetes, 2022 Health, Standard 24/09/2021 |